← Back
$VKTX All transactions

Viking Therapeutics, Inc.

▼ SELL

$ Value

$1.4M

Shares

38,989

Price

$35

Filed

Oct 28

Insider

Name

Lian Brian

Title

President & CEO

CIK

0001614578

Roles

Director Officer

Transaction Details

Transaction Date

2025-10-28

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,419,109

Footnotes

The reported securities were subject to a performance restricted stock unit award that was granted on January 3, 2025, 33.33% of which vested on October 27, 2025 upon the achievement of a non-financial performance goal and 15% of which vested also on October 27, 2025 upon the partial achievement of a non-financial performance goal. | These shares were automatically sold on a non-discretionary basis solely to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of certain shares of common stock subject to the performance restricted stock unit award described in Footnote 1. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.66 to $35.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the this footnote.

Filing Info

Accession No.

0001193125-25-254299

Form Type

4

Issuer CIK

0001607678

Lian Brian's History

Date Ticker Type Value
2026-01-05 VKTX $4.3M
2026-01-05 VKTX $1.8M
2026-01-05 VKTX $1.4M
2026-01-05 VKTX $224K
2026-01-02 VKTX A $0
2026-01-02 VKTX A $0
2026-01-02 VKTX A $0
2025-10-28 VKTX $1.4M
2025-10-27 VKTX A $0
2025-07-03 VKTX $748K

Other Insiders at VKTX (90d)

Insider Bought Sold Last
Aubuchon Neil William
Chief Commercial Officer
$150K 2026-03-10